IMS
ACAD icon

Index Management Solutions’s Acadia Pharmaceuticals ACAD Stock Holding History

Index Management Solutions’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-157
Closed -$7K – 710
2015
Q2 		$7K Buy
+157
New +$6.08K 0.01% 650
2013
Q4 		– Sell
-9,847
Closed -$270K – 662
2013
Q3 		$270K Buy
+9,847
New +$206K 0.08% 80

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Index Management Solutions's ACAD Position: Q3 2015 in Review

Index Management Solutions sold out of Acadia Pharmaceuticals (ACAD) in Q3 2015, closing a stake of 157 shares — an estimated $7K sold.

Index Management Solutions first reported a position in ACAD in Q3 2013 and held it in 2 quarters. The position peaked at $270K in Q3 2013. 187 funds tracked by Wall St. Rank hold ACAD as of Q3 2015.

  • Index Management Solutions reported no remaining Acadia Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Index Management Solutions sold 157 Acadia Pharmaceuticals shares in Q3 2015, an estimated $7K.
  • Index Management Solutions first reported a position in Acadia Pharmaceuticals in Q3 2013 and held it in 2 quarters.
  • Index Management Solutions's Acadia Pharmaceuticals position peaked at $270K in Q3 2013.
  • 187 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2015.

Based on Index Management Solutions's 13F filing for Q3 2015, filed 13 Nov 2015.